On November 22, 2013, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for delamanid, only the second new TB drug to be developed in 50 years. It is hoped that the new drug, marketed by the Japanese company Otsuka, will be pivotal in improving … Read more
Geneva, October 1, 2013. Today, Médecins Sans Frontières (MSF) welcomes Dr Joanne Liu as the new International President of the medical humanitarian organisation. Dr Liu was elected President during MSF’s International General Assembly in June 2013. “Today’s challenges in MSF are many,” says Dr Liu. “With contexts continually evolving, how do we deliver lifesaving medical … Read more
GENEVA/NEW YORK AUGUST 8, 2013—As Doctors Without Borders/Médecins Sans Frontières (MSF) begins vaccinating children against pneumonia in a refugee camp in South Sudan, the international medical humanitarian organization warned today that the global vaccination community is neglecting to provide new vaccines to crisis-affected children. While planning to immunize children against pneumococcal diseases in the Yida … Read more